NMPA Approval

Polatuzumab Vedotin for Injection

Approval Number

国药准字SJ20230003

Registration Date

January 10, 2023

Drug Information

Generic Name

注射用维泊妥珠单抗

Trade Name

优罗华

Dosage Form

注射剂

Strength

140mg/瓶

Drug Type

生物制品

Registration Date

January 10, 2023

Expiry Date

January 9, 2028

Company Address

Grenzacherstrasse 124, 4058 Basel, Switzerland

Company Address

Via Appia Km 65.561,04013 Latina Scalo(LT), Italy

Empowering clinical research with data-driven insights and AI-powered tools.

注射用维泊妥珠单抗 - NMPA 批准文号 | MedPath